Mammographic Density
8
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (8)
Karolinska Interventional Study of Mammograhic Density (Karisma-1)
RANKL Inhibition and Breast Tissue Biomarkers
Impact of Diet and Physical Activity Changes on Body Weight, Biomarkers and Quality of Life in Breast Cancer Survivors
The Malaysian Soy and Mammographic Density Study
Diffusion Magnetic Resonance Imaging in Mamographically Detected Asymmetric Densities
Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast Density
A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and Anastrozole
KEEPS Mammographic Density And Breast Health Ancillary Study